Free Trial

Toronto Dominion Bank Has $4.58 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein logo with Medical background

Toronto Dominion Bank grew its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 68.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 62,779 shares of the company's stock after acquiring an additional 25,474 shares during the period. Toronto Dominion Bank owned 0.05% of Henry Schein worth $4,577,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. American Century Companies Inc. increased its position in shares of Henry Schein by 3.1% in the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock valued at $351,543,000 after acquiring an additional 162,477 shares during the period. FMR LLC lifted its holdings in shares of Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company's stock worth $239,177,000 after buying an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP raised its position in Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after purchasing an additional 600,000 shares during the period. Nuance Investments LLC grew its holdings in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock worth $166,072,000 after purchasing an additional 414,748 shares during the last quarter. Finally, Burgundy Asset Management Ltd. increased its holdings in Henry Schein by 1.0% during the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock valued at $105,148,000 after buying an additional 16,476 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.14% of the company's stock.

Analyst Ratings Changes

HSIC has been the subject of several recent analyst reports. Evercore ISI lifted their price target on Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Barrington Research reissued an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price objective for the company. Finally, StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Seven analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Henry Schein presently has a consensus rating of "Moderate Buy" and an average price target of $78.89.

View Our Latest Research Report on Henry Schein

Henry Schein Price Performance

HSIC traded down $0.43 during midday trading on Friday, hitting $76.60. The company had a trading volume of 1,850,698 shares, compared to its average volume of 1,405,391. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a market capitalization of $9.55 billion, a PE ratio of 31.52, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm's 50-day simple moving average is $72.25 and its 200-day simple moving average is $70.06.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's quarterly revenue was up .4% compared to the same quarter last year. During the same quarter last year, the business earned $1.32 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should you invest $1,000 in Henry Schein right now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines